FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Comments Sought on 8 Drugs for WHO Scheduling

Federal Register notice: FDA seeks comments concerning abuse potential and the impact of scheduling changes on availability for medical use of eight d...

latest-news-card-1
Federal Register

Guide on Nitrosamine Acceptable Intake Limits

Federal Register notice: FDA makes available a final guidance entitled Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Imp...

latest-news-card-1
Human Drugs

Drger Recalls Carina Ventilators

Drgerwerk recalls its Drger Carina Sub-Acute Care Ventilators due to the potential for contamination of the breathing gas.

latest-news-card-1
Human Drugs

Orphan Status for BRAF Inhibitor

FDA grants ABM Therapeutics an orphan drug designation for ABM-1310, a novel small molecule BRAF inhibitor for treating patients with glioblastoma.

latest-news-card-1
Federal Register

Guide on Drug Supply Chain Security

Federal Register notice: FDA makes available a final guidance entitled Waivers, Exceptions, and Exemptions from the Requirements of Section 582 of the...

latest-news-card-1
Federal Register

K-TAB Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that KTAB (potassium chloride) extended-release tablets were not withdrawn due to safety or effectiveness conc...

latest-news-card-1
Federal Register

Figueroa Permanently Debarred by FDA

Federal Register notice: FDA permanently debars Raidel Figueroa from providing services in any capacity to a person that has an approved or pending dr...

latest-news-card-1
Human Drugs

Regeneron Prostate Cancer Trial Stops Enrollment

Regeneron says it has discontinued enrollment in a Phase 1 prostate cancer study of REGN5678, which is studying the combination use with a full-dose o...

latest-news-card-1
Human Drugs

FDA Floats AI Modeling to Help Assess Drug Safety

FDA discusses a new drug safety initiative that aims to develop artificial intelligence models for toxicological endpoints that are key to assessing d...

latest-news-card-1
Human Drugs

Nitrosamine Acceptable Intake Limits Guide

FDA releases a final guidance entitled Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs).